Rating: Cautiously Bullish | Target Price: HK$27-37 (base-case fair range, midpoint ~HK$31) | Current Price: HK$22.12 (2026-11-06 close) | Margin of Safety: +22% (vs. base-case fair value floor) | Time Horizon: 12-18 months
| Meta Info | Value |
|---|---|
| Total Share Capital / Market Cap | 823.72 million shares (539.4 million A-shares + 284.3 million H-shares) / ~HK$18.22 billion (~RMB 15.49 billion at 0.850289, as of ~2026-11-06) |
| PE(TTM) Attributable / Non-IFRS (deducting non-recurring items) | 16.1x / 25.4x (the non-recurring-adjusted multiple is inflated by the 2025Q4 loss quarter, of limited reference value) |
| 2026E Non-recurring-adjusted PE / PB | 14.6x / 2.16x (PB at a 1-year low, 25th percentile over 5 years) |
| Probability-Weighted Fair Value | ~HK$31.4 (bear 25% / base 55% / bull 20%), implying expected upside of ~+42% |
| Key Risks | Entity List supply chain escalation, memory cycle giveback, fair value noise, persistence of H-share discount |
Shanghai Fudan is the domestic FPGA leader and a platform for high-reliability specialty chips. FY2025 profit was driven to a trough by RMB 439 million of concentrated impairments (non-recurring-adjusted net profit of RMB 142 million, -69%), while non-recurring-adjusted net profit for the first three quarters of 2026 already reached RMB 769 million (+154%), with Q3 standalone gross margin at 63.26% — the V-shaped earnings reversal is confirmed by quarterly results; yet the stock has drawn down ~61% from its 52-week high and ~-53% year-to-date, with the H-shares trading at a ~60% discount to the A-shares. At HK$22.12, the stock trades at only ~14.6x 2026E non-recurring-adjusted earnings and ~18.2x normalized earnings (after stripping out cyclical components), below both its own historical median and specialty-IC peers; we judge it undervalued, with a base-case fair value of HK$27-37. However, three constraints must be clearly recognized: ~RMB 150-200 million of 2026 profit is reversible cyclical component (memory price hikes + impairment rollback); the attributable-profit metric is repeatedly disturbed by fair value swings of the SJ Semiconductor holding; and the H-shares' standalone collapse of ~47% from May to November (vs. ~-17% for the A-shares over the same period) shows the market's pricing of H-share structural factors (liquidity, shareholder base, Entity List tail risk) is not entirely irrational. We therefore assign a cautiously bullish rating with 0.58 confidence; the key validation node is the FY2026 annual report and incentive-plan assessment confirmation in January-March 2027.
Key evidence:
This report disaggregates the profit structure: of the RMB 466 million YoY increase in 9M non-recurring-adjusted profit, lower asset impairment losses contributed ~RMB 160 million (~34%) and higher other income ~RMB 52 million (~11%, mainly one-off in nature from the Huali government project acceptance), meaning ~46% of the increase did not come from operating volume/price expansion per se; moreover, FY2025 set a precedent of the year's largest impairment being concentrated in Q4 (Q4 standalone non-recurring-adjusted loss of RMB 161 million), so year-end inventory price tests could bring provisioning back. Therefore, the lower bound of the full-year non-recurring-adjusted range already incorporates RMB 50-100 million of Q4 provisioning risk — even so, the RMB 1.01 billion floor is still 7x FY2025's full year (RMB 142 million); the directional conclusion of a reversal is robust, but the slope must be stated conservatively.
Key evidence:
FPGA is the decisive battleground for this company's valuation: qualification barriers and radiation-hardening technology in the high-reliability (specialty/aerospace) space form an extremely deep moat, and the company is one of very few domestic vendors spanning both the "28nm giga-gate mass production for years + 1xnm billion-gate product" generations with in-house full-flow EDA. Two corrections make this thesis more robust: first, the annual report explicitly states the 1xnm billion-gate family has "completed tape-out, testing, and reliability verification and is advancing customer introduction" — this supports a post-2027 option rather than current revenue, with current growth still driven by 28nm giga-gate and high-reliability memory; second, in September 2025 the company, along with subsidiaries including Huali, was added to the US Entity List (Footnote 4) — the Entity List is both an accelerator of demand substitution (tightening overseas high-end FPGA access to China) and a constraint on the company's own advanced-node tape-out, 2.5D packaging, and overseas EDA access — the company hedges with ~RMB 2.1 billion of strategic raw material and WIP reserves and diversified supplier processes, but this two-sided nature caps this thesis at medium confidence.
Key evidence:
The base-case fair value arithmetic is fully transparent: 2027E non-recurring-adjusted earnings RMB 1.10-1.25 billion × exit PE 18-22x + net cash RMB 760 million = RMB 20.56-28.26 billion, or RMB 29.4-40.4/share, times a 0.92 one-year discount factor = HK$27.0-37.1. The exit PE anchors on three references independent of the company's current price: its own 3-year/10-year median PE(TTM) of 24.7x/22.9x, Unigroup Guoxin's non-recurring-adjusted ~34.9x discounted 35-45% for H-share liquidity to ~19-23x, and PEG≈1 implying ~16x — 18-22x takes the intersection of the three and already embeds an H-share liquidity discount rather than copying A-share multiples. The flip side of the current price: back-solving at 18-22x, the market is willing to pay only for sustainable non-recurring-adjusted earnings of RMB 700-780 million/year, a 25-30% discount to the 2026 annualized run-rate; PB 2.16x × 9M26 weighted ROE of 15.85% implies a perpetual growth rate of only ~3.5% — the market is pricing a company with growth across all five lines and Q3 gross margin at a three-year high as if it were near "zero growth." The reasons this thesis carries only 0.58 confidence: the implied-earnings back-calculation depends on multiple assumptions; and the H-shares' standalone ~47% decline from May to November 2026 (vs. ~-17% for the A-shares over the same period) suggests part of the discount may be structurally rational pricing rather than indiscriminate sell-off.
Key evidence:
The first constraint is earnings noise: fair value swings of the SJ Semiconductor (688820) holding cause large quarter-to-quarter swings in attributable profit (1H +RMB 466 million, Q3 -RMB 210 million); the market's doubts about "earnings quality" have a factual basis, and after the strategic placement lock-up expires in April 2027 the company can dispose and monetize, potentially clearing the noise (direction two-way). The second constraint is the cyclical component: memory-line 9M26 revenue of RMB 1.092 billion already exceeded FY2025's full year (volume and price both up), ~30% of revenue; of this, price hikes plus impairment rollback total ~RMB 150-200 million and are reversible — the 2027 giveback direction is clear but the slope uncertain (TrendForce expects high-density NOR contract prices to rise another 90-110% in 2H26; the company focuses on low-to-mid density, so timing may shift later). The third constraint is H-share structure: H/A discount of ~59.8% (A-shares at RMB 46.82 × FX = HK$55.06 vs. H-shares at HK$22.12), H-share average daily turnover of ~HK$100-130 million, and only 12 registered shareholders — there is no mechanism guaranteeing discount convergence; this report's base range already uses H-adjusted multiples, but if the discount widens further, valuation realization will be scaled down.
Key evidence:
Positive reading: the path from Fudan University-affiliated shareholders exiting to Shanghai municipal state capital entering is established; within the 18-month lock-up (to ~April 2028) there is no sell-side supply, and expectations of synergies — Guosheng-affiliated industry funds, a joint innovation center with Fudan University, etc. — form a medium-term narrative. Facts that must be recorded simultaneously: RMB 48.14/share (post-dividend-adjusted total price RMB 5.138 billion) was a negotiated price between state-capital parties, not market pricing, and the current A-share price of RMB 46.82 is already below it — treating it directly as a "value floor" is dangerous; after the lock-up expires, that block still constitutes potential A-share supply; JPMorgan's October increase of only 780 thousand shares (~0.1% of market cap, including derivatives and securities lending proxies) and A-share sell-side bullishness (all published before the Q3 report, 3-firm sample) are at best weak corroboration. This thesis's real value lies in timing: the FY2026 annual report (January-March 2027 window) will simultaneously confirm full-year earnings, incentive assessments, and the first annual report since state capital's entry — the convergence point of multiple validations.
| Metric (RMB 100 million) | FY2023 | FY2024 | FY2025 | 2026 9M |
|---|---|---|---|---|
| Revenue | 35.36 | 35.90 | 39.82 | 35.64 (+17.8%) |
| Attributable net profit | 7.19 | 5.73 | 2.32 | 10.60 (+221.1%) |
| Non-recurring-adjusted attributable net profit | 5.72 | 4.64 | 1.42 | 7.69 (+153.8%) |
| Overall gross margin | 61.21% | 55.95% | 56.19% | 59.34% (Q3 standalone 63.26%) |
| Attributable net margin | 20.35% | 15.95% | 5.83% | 29.75% (incl. fair value) |
| Operating cash flow | -7.08 | 7.32 | 7.84 | 7.95 (+89.8%) |
| Free cash flow (OCF-CapEx) | -15.59 | 1.00 | 5.19 | 6.07 |
| Capital expenditure | 8.51 | 6.33 | 2.65 | 1.89 |
| Cash + trading financial assets (stock, 2026-09-30) | — | — | — | 20.65 |
| Interest-bearing debt (2026-09-30) | — | — | — | 13.07 (net cash +7.58) |
| Debt-to-asset ratio | — | — | — | 21.78% (2026-09-30) |
Reasons for metric changes (company explanations attached for all items with YoY ≥ ±20%): FY2025 attributable profit -59.4% — asset impairment losses of RMB 439 million (company: downstream demand mix changes for stocked products, sales below expectations, inventory write-downs of RMB 420 million + intangible asset impairment of RMB 18 million), R&D expenses +18.6% (write-off of partially capitalized projects into expenses), other income -38.8% (reduced VAT super-deductions and government grants); 2023 OCF/FCF deeply negative — surge in cash payments for strategic stockpiling + peak Lingang test-base construction; 2025 CapEx -58% — investment peak passed after Lingang base transferred to fixed assets; 2026 9M attributable profit +221% — company attributes to "sales and gross profit growth across product lines and a sharp decline in inventory write-down losses," additionally including SJ Semiconductor fair value of +RMB 258 million cumulatively over 9M.
Q3 standalone revenue RMB 1.338 billion (+12.9%), attributable profit RMB 211 million (+54.6%), non-recurring-adjusted RMB 357 million (+196.0%) — attributable growth trailed non-recurring-adjusted due to a standalone fair value change of -RMB 210 million (SJ Semiconductor share price drawdown); excluding that noise, core profitability was the best in three years: standalone gross margin 63.26% (+2.2pp YoY), standalone non-recurring-adjusted net margin 26.7%. By line, FPGA and other products reached RMB 1.196 billion in 9M26 (~+25% YoY) and memory RMB 1.092 billion (already exceeding FY2025's full year; Q3 standalone ~RMB 471 million, +44% QoQ). Against sell-side consensus (2026E attributable profit RMB 1.258 billion, published before the Q3 report): extrapolating from 9M actuals and Q4 inertia, this report projects attributable profit of RMB 1.26-1.41 billion and non-recurring-adjusted RMB 1.01-1.11 billion, at the upper end of consensus — i.e., the bar for "beating consensus" is not high, but the market currently cares more about earnings quality than growth rate (the H-shares' 3.27% post-results decline is evidence), and repair requires the annual report and 2027Q1 data to take the baton.
Model in brief: Fabless asset-light chip design (FPGA/memory/security & identification/metering MCU) + heavy-inventory strategic stockpiling (inventory of RMB 2.662 billion as of 2026-09-30, ~26% of total assets, of which ~RMB 2.1 billion is raw materials and work-in-progress—under the Entity List backdrop this carries dual attributes of a safety cushion and impairment exposure) + controlled heavy-asset testing platform Hua Ling (persistently loss-making, FY2025 net loss of RMB 56 million). Revenue comes primarily from one-off product sales with no subscription-type recurring revenue; pricing power is bifurcated—the specialty/high-reliability line enjoys quasi-monopoly qualification-based pricing, while the civilian line follows the market.
Cash content of earnings: OCF/attributable net profit for 2023–2026H1 was -0.98 (stockpiling year) / 1.28 / 3.38 (inflated by impairments depressing profit) / 0.91 respectively; FCF/net profit was -2.17 / 0.17 / 2.23 / 0.76. The normal range of ~0.8–1.3 is healthy; the 2023 anomaly resulted from proactive stockpiling plus the Lingang base double-hit, and the company turned positive within two years—cash flow discipline is verifiable. Recurring earnings test: in 2026H1, non-recurring gains/losses of RMB 437 million accounted for 51.5% of attributable profit (fair-value driven); earnings must be assessed on an ex-non-recurring basis—9M26 ex-non-recurring profit reached RMB 769 million, with operating cash flow of RMB 795 million providing 1.03x coverage.
Return on capital: FY2025 ROIC was only ~2.3% (impairment trough year), while 9M26 weighted ROE has recovered to 15.85% (+10.4pp)—normalized 2026E ROIC is estimated at ~13%, above the estimated 10.5% WACC line. The "trough-ROIC trap" has been released, but the track record is short; another full year of observation is required.
CapEx quality: CapEx of RMB 851→633→265 million (2023–2025), CapEx/D&A of 1.91→0.67—the Lingang testing base construction peak has passed; the company does not disclose a maintenance/growth split, so precise differentiation is impossible, but current investment intensity is at a low level and the structural window for FCF turning positive is clear.
Red flags and cash conversion signals: ① High inventory ratio with provision coverage already at 24.07% (balance of RMB 804 million); ② Accounts receivable of RMB 2.405 billion (+28.2% from the start of the year, faster than revenue growth); H1 receivables + notes/revenue reached 108.16% (long settlement cycles of high-reliability customers; Unigroup Guoxin's comparable ratio is even higher—a specialty-sector commonality, but still on a deteriorating path); ③ Hua Ling losses; ④ Ex-non-recurring reliance on government subsidies and tax incentives (see E4).
Consistency of words and actions: pragmatic and somewhat conservative, verifiable. ① The 2024 annual report outlook of "gradual industry recovery, profits pressured by incentive expenses and impairments" → 2025 revenue +10.9% delivered, but the profit collapse (-59%) exceeded its conservative wording; ② The 2025 annual report risk section self-warned that "differences between 2026 revenue and investment pacing could cause performance decline" → actual 9M ex-non-recurring profit +154%, far exceeding its conservative tone; ③ The 2026-10-15 positive profit alert gave ranges for three metrics (revenue/attributable/ex-non-recurring) → actual results on 10-28 all fell within the ranges. Its promise-to-delivery record shows no history of exaggeration, and guidance habitually carries a safety margin.
Shareholder friendliness: neutral-to-weak. Payout ratio of 9.13% (FY2023) → 11.48% (FY2024) → 20.56% (FY2025)—the ratio rose but absolute amounts fell (RMB 65.71 million → 47.78 million); dividend yield at the current price is below 1%; no buybacks; 13.88 million shares reserved for 2026 incentives (~1.68%) + rising share-based payment expenses (RMB 40.9973 million in 2026H1). In its semi-annual "quality improvement, efficiency enhancement, and enhanced returns" review, the company explicitly stated it is "studying A+H multiple dividends per year"—a plus item in gestation but not yet delivered. If the FY2026 annual report payout ratio rises to 30% (on an attributable profit base of RMB 1.26–1.41 billion), it would be a substantive improvement signal.
Risk signals: No controlling shareholder and no actual controller (governance structure still being restructured after state capital became the largest shareholder); sizable related-party transactions (2025 related-party sales of RMB 351 million, 8.82% of revenue; related-party purchases 11.06%; the industry fund's GP and the largest shareholder both belong to the Guosheng group); expanded disclosure exemptions for certain supply chain arrangements and customer names starting from the 2025 annual report; June 2025 board reconstitution (Zhang Wei as Chairman and General Manager). Note: Regarding the departing executive's 2025 share sales, two independent checks produced conflicting results (mentioned in the annual report vs. no record found in public equity disclosures); this report does not adopt that account and will track and verify it going forward.
| Segment (FY2025) | Revenue Share | Gross Margin | YoY | One-line Business Logic |
|---|---|---|---|---|
| FPGA and other products | 35.5% | 74.82% | +25.19% | Billion-gate-class + PSoC/RFSoC/FPAI portfolio; high-reliability + specialty qualification moat |
| Non-volatile memory | 26.2% | 66.08% | -8.30% | High-reliability memory + civilian NOR/NAND; competitive decline in 2025, volume-price upswing in 2026 |
| Security & identification chips | 21.5% | 29.85% | +8.08% | Mature smart IC card base + RFID/NFC IoT ramp; lowest-margin core line |
| Smart metering chips | 13.0% | 39.57% | +30.69% | >60% share in metering MCUs; automotive-grade MCU volume doubled |
| IC test services (Hua Ling) | 3.6% | 16.31% | +8.78% | Heavy-asset testing platform; new AI chip testing track; still loss-making |
The profit engine is FPGA, not what the revenue share suggests: Using "revenue share × gross margin," FPGA and other products contribute ~47% of the company's gross profit (35.5% × 74.82% vs. total gross margin of 56.19%), making it the only dual engine of "high margin + high growth"; the memory line has the greatest elasticity in 2026 but the strongest cyclicality; security & identification contributes revenue but not profit elasticity; Hua Ling is a strategic positioning, not a profit source. The reason for the gross margin spread of 74.82% vs. 16.31% (58.5pp): the former is a pricing-power business built on specialty qualifications and generational barriers, while the latter is a fully competitive foundry service and mature-node card chip business—the consolidated "56% gross margin" masks two entirely different businesses. 9M26 dynamics: FPGA RMB 1.196 billion (~84% of full-year FY2025) and memory RMB 1.092 billion (already exceeding full-year FY2025)—the combined share of the two high-margin lines is rising, a structural driver of the Q3 single-quarter gross margin of 63.26%.
Accounting red flags (by severity): ① Sharp volatility in inventory impairment provisions, concentrated at year-end—asset impairment losses of RMB 169 million (2024) → RMB 439 million (2025, of which ~RMB 240 million concentrated in Q4, single-quarter ex-non-recurring loss of RMB 161 million) → RMB 40 million (9M26), with clear "year-end big bath" characteristics (medium); ② R&D capitalization ratio plunging from 20.36% → 8.94%, accompanied by development cost write-offs—high policy flexibility with room for cross-period adjustment (medium); ③ Abnormally low effective tax rate—FY2025 pre-tax profit of RMB 202 million with only RMB 679 thousand in taxes paid (0.34%), relying on R&D super deductions, deferred taxes, and prior-year adjustments; recovered to ~2.5% in 9M26, still far below the 15% high-tech rate—high structural reliance of earnings on tax incentives and subsidies (low-medium); ④ 2026H1 reversal of provisions of RMB 31.84 million boosted profit, in the opposite direction of current-period provisioning (low); ⑤ Expanded disclosure exemptions (supply chain arrangements + customer names), raising the difficulty of third-party verification (low).
Cross-period consistency: ① Non-recurring gains/losses as a share of attributable profit: 20.4% (2023) → 18.9% → 38.7% → 51.5% (2026H1); the jump was driven by fair-value changes in Shenghe Jingwei, with itemized details in each period consistent with company explanations; ② Receivables/revenue rising year by year: 26.3%→41.6%→47.1%; the company's explanation (long high-reliability customer settlement cycles + sales growth) is directionally consistent, but the trend itself is a negative for earnings quality; ③ Operating cash flow swinging sharply from -708 → +732 → +784 million RMB, matching the strategic stockpiling cycle and consistent with company explanations; ④ Attributable net profit showing a four-year V-shape (1,077→719→573→232 million, 9M at 1.060 billion), with period attributions (price cuts → impairments → impairments + write-offs → volume-price gains + impairment decline) coherent throughout. Overall judgment: no signs of systematic fraud found, but the timing concentration of impairment provisions and reliance on tax incentives represent real accounting flexibility; simply track their quarterly distribution.
Current market data (closing price 2026-11-06): H shares at HK$22.12, market cap HK$18.22 billion (~RMB 15.49 billion); PE (TTM attributable) 16.1x—1-year low, 30th percentile of 3 years; PB 2.16x—1-year low, 25th percentile of 5 years; PS (TTM) 3.4x. Percentile basis must be stated: TTM attributable profit is close to the normalized center (including the 2025Q4 loss quarter and 2026 memory elasticity); static PE of 70.8x (FY2025 trough earnings) is completely distorted and should not be used; ex-non-recurring TTM of 25.4x is inflated by the 2025Q4 single-quarter loss. Growth basis: 2026E ex-non-recurring 14.6x, normalized ex-non-recurring 18.2x, PEG ~0.75–0.94.
Peer benchmarks (multiples at 2026-11-06 close or latest snapshot):
| Company | PE(TTM) | PB | Growth | ROE | Key Differences |
|---|---|---|---|---|---|
| Fudan Micro H (01385) | 16.1 (attributable) / 14.6 (2026E ex-non-recurring) | 2.16 | 9M26 ex-non-recurring +154% | 9M26 weighted 15.85% | Subject of this report; H-share liquidity discount |
| Unigroup Guoxin (002049.SZ) | ~34.9 (ex-non-recurring, low base) | 2.94 | FY2025 attributable +21.9%; 9M26 -17.2% | 2025: 11.0% | Specialty IC leader; claims 60%+ share in aerospace FPGA; direct competitor |
| Anlogic (688107.SH) | Loss-making, PE meaningless | 5.35 | 9M26 revenue +100% (low base) | Negative | Pure civilian FPGA, consecutive losses;景气 elasticity reference |
| Lattice (LSCC.US) | GAAP ~283x (distorted) | — | Latest quarter revenue +118% (AI servers) | 1–3% | Low-power niche leader; AI elasticity premium reference (PS ~17.7x) |
| AMD (incl. Xilinx) | GAAP ~140x | — | FY2025 revenue +34% | 7.2% | Global FPGA leader (51.7% share); high-end China access restricted by export controls |
Market-implied expectations: Back-solving from a fair multiple of 18–22x, the current price implies sustainable ex-non-recurring profit of ~RMB 700–780 million/year—a 25–30% discount to the 2026 annualized run-rate (~RMB 1.03 billion); PB 2.16x × ROE 15.85% implies a perpetual growth rate of only ~3.5%. One-line comparison: the current price requires earnings to "retreat" to ~70% of the 9M26 single-quarter annualized run-rate and stagnate in perpetuity, whereas reality shows five lines growing in tandem, a record-high Q3 gross margin of 63.26%, and operating cash flow covering ex-non-recurring profit 1.03x. The mispricing has causes: ~RMB 150–200 million of cyclical component + fair-value noise + H-share liquidity structure—the market is pricing in "half the profit as illusion." The error has its reasons, but even after fully stripping out the cyclical component, 18.2x remains below its own historical median (24.7x) and the H-discount-adjusted peer level (19–23x).
Three-tier value (EPV): Asset value ~HK$10.33/share (2026-09-30 attributable net assets of RMB 7.236 billion at 1x PB, as a floor reference); zero-growth EPV ~HK$11.46/share (normalized FCFF of ~RMB 760 million ÷ 10.5% discount rate + net cash; normalized basis = 2026 annualized run-rate excluding ~RMB 100 million of memory price gains and ~RMB 100 million of impairment-reversal elasticity); current price HK$22.12 − EPV ≈ HK$10.7 paid for growth (~48.2% of the current price, per this report's unified basis calculation). The growth option component is not negligible—one cannot conclude that "the market pays only for zero growth"; whether this share is reasonable is determined by ramp scenarios: the incentive assessment anchor implies a 2024–2028 CAGR of ~13.3% for FPGA + high-reliability memory, plus options in billion-gate-class adoption, satellite constellations, and FPAI edge AI—a 48% growth premium corresponding to a ~13% segment CAGR is not aggressive, but requires FY2027 annual report validation.
Three scenarios and odds (12–18 months):
| Scenario | Probability | Fair Range (HK$) | vs. Current Price | Key Swing Factors |
|---|---|---|---|---|
| Bear | 25% | 12–14.5 | -46% to -34% | Entity List escalation restricting advanced-node tape-out/packaging + Shenghe Jingwei value give-back + memory price war: 2027E ex-non-recurring falls back to RMB 550–600 million × 15–16x + net cash; PB trough of 1.25x cross-validates ~HK$13.6 |
| Base | 55% | 27–37 | +22% to +67% | Moderate memory give-back, FPGA/metering/security continued growth: 2027E ex-non-recurring RMB 1.1–1.25 billion × 18–22x + net cash, one-year discount factor 0.92 |
| Bull | 20% | 47–58 | +112% to +162% | FPAI edge AI ramp + billion-gate-class volume + constellation acceleration + extended memory upcycle: 2027E ex-non-recurring RMB 1.35–1.45 billion × 26–30x growth re-rating (benchmarking market-based pricing of LSCC/Anlogic, adjusted for H liquidity) |
Probability-weighted fair value ~HK$31.4 (expected upside ~+42%); the current price sits at the lower part of the distribution—odds are asymmetrically positive, but the bear-case tail of -34% to -46% cannot be ignored. External anchor check: the most pessimistic verifiable foreign target price is Morgan Stanley's HK$13 (2024-12-11, "Equal-weight," assuming FPGA share of 13% and 2024–26 operating margin of 16%—predating the Entity List and the 2026 reversal, an outdated reference; it was raised to HK$32.8/Overweight in 2025-09). At the most optimistic end, the A-share consensus target price average is RMB 59.82 (3 analysts, small sample; ~HK$70 equivalent, A-share basis). This report's bear case of 12–14.5 overlaps in magnitude with the old Morgan Stanley value but on different grounds (theirs was an earnings assumption downgrade; ours is a supply-shock stress test), and it is not adopted as a boundary.
This report's earnings forecast (reconciliation anchor):
| Period | Revenue (RMB 100M) | Attributable / Ex-non-recurring (RMB 100M) | Key Drivers |
|---|---|---|---|
| FY2026E | 48–50 | 12.6–14.1 / 10.1–11.1 | FPGA RMB 1.66–1.72 billion (+18–22%); memory RMB 1.52–1.58 billion (+46–51%, slight decline from Q4 highs); security RMB 960–990 million; metering RMB 580–600 million; testing RMB 165–175 million; gross margin 59–60% |
| FY2027E | 55–60 | 13.5–15.5 / 11.5–13.0 | FPGA +25–30% (billion-gate-class adoption + RFSoC volume + FPAI); memory -5% to +5% (largest uncertainty); gross margin 58–60% |
Comparison with management guidance: the company provides no quantitative guidance (only qualitative operating plans); the conservative risk warnings in the 2025 annual report have been substantially exceeded by actual results. Against sell-side consensus (2026E attributable RMB 1.258 billion / 2027E RMB 1.409 billion), this forecast sits at the upper-middle of that range, with differences mainly in the memory give-back assumption.
Conclusion: Undervalued. Quality (gross margin 59–63%, ROE back above 15%, net cash, R&D intensity 25%) and price (14.6x 2026E ex-non-recurring, 1-year-low PB) are clearly disconnected; target price HK$27–37 = base-case fair value, safety margin (base-case floor) +22%. The base-case exit PE of 18–22x is anchored on the intersection of "own 3-year/10-year medians of 24.7x/22.9x × H-share liquidity discount + Unigroup Guoxin H-adjusted 19–23x + PEG≈1 at ~16x"—independent of the company's current 16.1x (the current multiple serves only as a reference, not an anchor, to avoid circular reasoning).
Industry size. Global FPGA market: per Frost & Sullivan, ~US$6.86 billion in 2021 → projected US$12.58 billion by 2025 (CAGR 16.4%); per MarketsandMarkets, US$11.73 billion in 2025 → US$19.34 billion by 2030 (CAGR 10.5%); Intel (Altera) officially forecasts a 10%+ CAGR over the next five years. China market (F&S, as cited via Debang Securities' industry deep-dive): FPGA chip sales of ~RMB 33.22 billion and shipments of ~330 million units in 2025, with a 2021-2025 CAGR of 17.1%—China's growth rate exceeds the global rate by roughly 6-7 percentage points, and that excess is precisely domestic substitution plus premiumization. Downstream structure: industrial control + network communications together account for ~73% (2019 China basis, F&S); data center/AI acceleration is the fastest-growing direction globally (fastest growth at ≤16nm nodes). Background caveat: the 2026 global semiconductor sales forecast of US$1.51 trillion (WSTS, +89.9%) is an extreme figure driven by memory price surges; it serves only as sentiment backdrop and does not constitute independent evidence for company demand.
Quantified chain of the demand inflection (LEO satellites). This is the clearest exogenous demand restructuring in the industry: satellite internet is shifting from "custom single-satellite" to "mega-constellation mass production"—the Qianfan (Spacesail) constellation has 218 satellites in orbit (per MIIT, 2026-07-04), with Phase I planned at 648 satellites and 1,296 before 2027; the GW (Guowang) constellation plans ~13,000 satellites; combined plans total ~25,000 satellites, currently at a pace of ~1-2 batches of "18 satellites per rocket" per month. The addressable market for spaceborne phased-array T/R modules is estimated at ~RMB 86.37 billion (Soochow Securities? Huaxi Securities: ~300 T/R modules per satellite × RMB 13,500-16,500 each); under the digital beamforming (DBF) trend in LEO communication payloads, beam management/payload processing/inter-satellite links all require high-capacity FPGAs—the company's gigagate-scale radiation-hardened FPGA is a key component in spaceborne phased-array signal processing (Guosheng Securities, 2026-04), and it offers a full suite of spaceborne solutions—FPGA/RF-FPGA/PSoC/RFSoC/Flash/dedicated refresh chips—plus a fully homegrown EDA flow (2026 interim report). Honest boundary: no first-hand authoritative figures exist for "FPGA content per satellite × company share"; on assumptions of RMB 300K/500K/800K per satellite, the remaining 430 satellites of Qianfan Phase I alone imply incremental revenue of RMB 130-340 million—the direction of this chain is certain, but the magnitude awaits disclosure for verification. This report does not include it in the base earnings forecast; it is treated only as an option. AI server penetration (competitor Anlogic has entered board-level management) lacks sufficient evidence and is likewise only a watch item.
Industry chain and value distribution. The FPGA value chain: EDA tools and IP (internationally monopolized by Synopsys/Cadence/Siemens; the company's in-house full-flow toolchain is a scarce capability) → wafer foundry (advanced logic capacity concentrated at TSMC and SMIC, constrained by U.S. FDP rules) → packaging and test (2.5D advanced packaging depends on SJ Semiconductor and the like). The company sits in the design segment (fabless), where most gross profit is retained (overall gross margin 56-63%; FPGA line 74.8%); its bargaining power over upstream foundries is weaker than overseas leaders (supply assurance takes priority during capacity shortages; the company hedges with RMB 2.1 billion of strategic inventory); its bargaining power over downstream defense/specialty customers is strong (qualification barriers + long design-in validation cycles + customer switching costs), while on the civilian side it is weak (equipment vendors' multi-sourcing squeezes prices). Specialty/aerospace-grade qualification (radiation hardening, multi-year design-in cycles) is the deepest moat segment in the chain.
Supply-demand and competitive landscape. Global oligopoly: four majors—AMD (Xilinx), Intel (Altera), Lattice, Microchip—with shipment-based CR4 = 94.4% in 2019 (AMD 51.7%, Intel 33.7%, F&S); by FY2025 revenue, AMD Embedded (incl. Xilinx) US$3.5 billion, Lattice US$523 million, Fudan Micro's FPGA and other ~US$200 million order of magnitude—the gap remains roughly tenfold. Domestically there are ~8 vendors, and only four have gigagate-scale FinFET R&D capability: Unigroup SoC (Ziguang Tongchuang), EASIC (Zhongwei Yixin), Fudan Microelectronics, and Efinix (per EEWorld/International Electronics Business, 2025-03 industry map); domestic vendors' combined revenue rose from ~RMB 200 million in 2018 to ~RMB 3.3 billion in 2022 (Debang estimate), against a China market of ~RMB 20.7 billion that year—rough domestic penetration estimated at ~16%—substitution depth being the source of the industry's excess growth. Fudan Micro's FPGA revenue of ~RMB 1.414 billion is roughly ~4.3% of the China market. The current supply-demand state is "differentiated tight balance": civilian mid/low-end is oversupplied with fierce price wars (Anlogic's FPGA gross margin fell to 32.4% in 2024, four consecutive years of losses; the company's civilian products show volume up, price down), while high-reliability/specialty and high-end domestic supply is scarce (the company's FPGA gross margin of 74.8% and a Q3 overall gross margin uptick of +5.5pp QoQ are evidence). Entry barriers are extremely high: the trinity of architecture + full-flow EDA + IP ecosystem (Xilinx/Altera patent walls of 6,000+ items), advanced-node tape-out and mass-production experience, specialty qualification credentials, and downstream software asset ecosystem lock-in (FPGA life cycles of 10-20 years).
Cycle and regulation. Semiconductors are in a strong AI-driven upcycle; the FPGA segment is in a phase of "civilian bottoming/recovery + structural upcycle in specialty/AI," with the prosperity inflection confirmed between 2025Q3 and 2026Q1 (company FPGA revenue growth +25.3% in 2025; Anlogic revenue +100% in the first three quarters of 2026). Leading indicators: FPGA lead times (45-65 weeks in 2022 was the previous cycle's peak signal), price-hike letters from leaders, adjustments to the company's related-party transaction quotas (2025-07: quota with Fudan Communications for 2025-2027 raised to RMB 520 million—a forward-looking demand signal), and sequential gross margin moves. Regulation is a two-way variable: on the U.S. side—the 2022-10 advanced computing rules, 2024-12 HBM/equipment FDP new rules, 2025-09-12 listing of the company and subsidiaries on the Entity List (Footnote 4), and 2026-05-31 BIS guidance on piercing review of China-headquartered entities—this blocks overseas competitors' high-end supply in China (positive for substitution demand) while constraining the company's own access to overseas EDA and advanced capacity (negative for supply). On the China side—the Big Fund Phase III (registered capital RMB 344 billion) and rising domestic-content ratios in Xinchuang and specialty procurement provide dual support from demand and capital. Net effect: modestly positive for leading vendors like the company that possess full-flow indigenous capability and specialty qualifications, but supply-side exposure means the "net positive" must be continuously reassessed.
Peer benchmarking (Fudan Micro figures are 9M26/FY2025 basis; peers per the valuation table in the prior section): versus Unigroup Guoxin (specialty IC leader, 2025 revenue RMB 6.146 billion, specialty gross margin ~70%), the company is roughly 60% of its size, competing head-on in the specialty niche (the rival claims 60%+ share in aerospace-grade FPGA; the company is a key supplier for spaceborne phased arrays—two figures from their respective disclosures, no authoritative third-party share data; presented side by side for reference). Versus Anlogic (2025 revenue RMB 520 million, loss-making), the company's FPGA business is ~2.7x larger and profitable—"specialty high-reliability + platformization" crushes "purely civilian" on profitability (gross margin 56% vs 43%). Versus Lattice, the routes are misaligned (high-reliability high-capacity vs low-power niche). Versus AMD, a generational gap of about two nodes (7nm/Versal vs 1xnm catching up), but export controls restrict the latter's high-end supply in China—the catch-up window is being held open by policy.
Company positioning in the industry: leader in the specialty track + chaser in civilian high-end. Share trend rising (FPGA revenue growth +25% outpacing the China market CAGR of 17.1%); four pillars of the moat: specialty/aerospace qualifications and radiation-hardening technology, 28nm→1xnm full-flow in-house design + proprietary EDA toolchain, complete spectrum of 50K-4000K logic resources + 2.5D packaging initiatives, FPGA+memory+security+MCU platform synergies, and binding to domestic advanced foundry capacity. Principal constraints: the civilian mid-range price war and the substantive constraint of the Entity List on advanced-node iteration.
Stance: cautiously bullish, confidence 0.58, 12-18 months. Separating price from quality is the core of this case: fundamentals are at the starting point of a "cycle reversal + structural growth" resonance (ex-non-recurring +154%, gross margin 63.26%, OCF coverage of 1.03x), while the price sits at a 1-year low percentile (PB 2.16x, 2026E ex-non-recurring P/E 14.6x); base fair value HK$27-37, margin of safety +22% (lower-bound basis). Why "cautious": expected upside depends on an H-share valuation re-rating, and the H-share structural discount (59.8%) carries no mechanical guarantee of convergence; ~46% of the ex-non-recurring profit increment comes from non-repeatable items (lower impairment provisions and other income); an escalation of the Entity List on the supply side (low probability but high impact) could break the valuation thesis. Strategically, the current level offers left-side allocation value, but tolerance before validation checkpoints must be measured in "quarters."
Monitoring points (next 12 months): ① FY2026 annual report window (Jan-Mar 2027, per last year's 3-27 disclosure rhythm; full-year earnings preview may come earlier in Jan-Feb)—ex-non-recurring vs the RMB 1.01-1.11 billion range, Q4 impairment provisions, confirmation of incentive-plan targets met, and the new 2027 anchor of RMB 2.52 billion; ② direction of memory line pricing and revenue in 2027Q1 (whether the cyclical give-back materializes); ③ the April 2027 unlock of SJ Semiconductor's strategic placement stake and the company's disposal decision (clearing fair-value noise); ④ RFSoC advancing from "customer design-in" to "volume supply" and announcements of gigagate-scale 1xnm orders; ⑤ Qianfan/GW constellation launch cadence (monthly); ⑥ Guosheng-affiliated capital moves (share increases / first industrial-fund investment / upgraded dividend policy) and the moves of Fudan Fukong (still holding 11.35%). Contrarian triggers: FY2026 ex-non-recurring below RMB 800 million, single-year impairments back above RMB 250 million, BIS restrictions on domestic foundry/packaging affecting the company's services, or H-share close below HK$16 (bear case approaching)—any single trigger warrants a full reassessment of this framework.
This report is based on the closing price of 2026-11-06 (HK$22.12) and the most recent publicly available information (materials published on 2026-11-07, retrieved after 2026-11-06, have also been referenced). Financial data are sourced from the company's HKEX disclosures (FY2023-FY2025 annual reports, 2026 interim and Q3 reports, profit alerts, and shareholder announcements); industry data from Frost & Sullivan (as cited via Debang Securities), MarketsandMarkets, WSTS, MIIT, etc.; exchange rate HK$1 = RMB 0.850289 (around 2026-11-06). This report does not constitute investment advice.